Literature DB >> 19506062

Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum.

Nicanor Obaldia1, Barbara M Kotecka, Michael D Edstein, Richard K Haynes, Burkhard Fugmann, Dennis E Kyle, Karl H Rieckmann.   

Abstract

Artemisone (single oral dose, 10 mg/kg of body weight) cured nonimmune Aotus monkeys of their Plasmodium falciparum infections when combined with mefloquine (single oral dose, 5 and 10 mg/kg but not 2.5 mg/kg). In combination with amodiaquine (20 mg/kg/day), artemisone (10 mg/kg/day) given orally for 3 days cured all infected monkeys. Three days of treatment with artemisone (30 mg/kg/day) and clindamycin (100 mg/kg/day) was also curative.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506062      PMCID: PMC2715646          DOI: 10.1128/AAC.00471-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.

Authors:  F Nosten; M van Vugt; R Price; C Luxemburger; K L Thway; A Brockman; R McGready; F ter Kuile; S Looareesuwan; N J White
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

2.  Determination of the drug sensitivity of Plasmodium falciparum.

Authors:  K H Rieckmann
Journal:  JAMA       Date:  1971-08-02       Impact factor: 56.272

3.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

4.  Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.

Authors:  A Brockman; R N Price; M van Vugt; D G Heppner; D Walsh; P Sookto; T Wimonwattrawatee; S Looareesuwan; N J White; F Nosten
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

Review 5.  Antimalarial drug resistance.

Authors:  Nicholas J White
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

6.  Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon.

Authors:  P G Kremsner; S Winkler; C Brandts; S Neifer; U Bienzle; W Graninger
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

7.  Artesunate combinations for treatment of malaria: meta-analysis.

Authors:  M Adjuik; A Babiker; P Garner; P Olliaro; W Taylor; N White
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

8.  Neurotoxicity in animals due to arteether and artemether.

Authors:  T G Brewer; J O Peggins; S J Grate; J M Petras; B S Levine; P J Weina; J Swearengen; M H Heiffer; B G Schuster
Journal:  Trans R Soc Trop Med Hyg       Date:  1994-06       Impact factor: 2.184

9.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

10.  Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria.

Authors:  K H Rieckmann; G M Trenholme; R L Williams; P E Carson; H Frischer; R E Desjardins
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

View more
  10 in total

1.  Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.

Authors:  Jin Guo; Armand W Guiguemde; Annael Bentura-Marciano; Julie Clark; Richard K Haynes; Wing-Chi Chan; Ho-Ning Wong; Nicholas H Hunt; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether.

Authors:  Ryan C Conyers; Jennifer R Mazzone; Maxime A Siegler; Abhai K Tripathi; David J Sullivan; Bryan T Mott; Gary H Posner
Journal:  Bioorg Med Chem Lett       Date:  2014-01-30       Impact factor: 2.823

3.  In Vivo Efficacy and Pharmacokinetics of the 2-Aminomethylphenol Antimalarial JPC-3210 in the Aotus Monkey-Human Malaria Model.

Authors:  Fiona J McCallum; Geoffrey W Birrell; Marina Chavchich; Ivor Harris; Nicanor Obaldia; Karin Van Breda; Gavin D Heffernan; David P Jacobus; Dennis Shanks; Michael D Edstein
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 4.  Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges.

Authors:  Kashyap Patel; Julie A Simpson; Kevin T Batty; Sophie Zaloumis; Carl M Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

Review 5.  Recent advances in malaria drug discovery.

Authors:  Marco A Biamonte; Jutta Wanner; Karine G Le Roch
Journal:  Bioorg Med Chem Lett       Date:  2013-03-27       Impact factor: 2.823

6.  Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Authors:  W Armand Guiguemde; Nicholas H Hunt; Jintao Guo; Annael Marciano; Richard K Haynes; Julie Clark; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

7.  Assessment of the induction of dormant ring stages in Plasmodium falciparum parasites by artemisone and artemisone entrapped in Pheroid vesicles in vitro.

Authors:  Lizette Grobler; Marina Chavchich; Richard K Haynes; Michael D Edstein; Anne F Grobler
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

8.  Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.

Authors:  Jutta Marfurt; Ferryanto Chalfein; Pak Prayoga; Frans Wabiser; Grennady Wirjanata; Boni Sebayang; Kim A Piera; Sergio Wittlin; Richard K Haynes; Jörg J Möhrle; Nicholas M Anstey; Enny Kenangalem; Ric N Price
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

9.  Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model.

Authors:  Nicanor Obaldía; Geoffrey S Dow; Lucia Gerena; Dennis Kyle; William Otero; Pierre-Yves Mantel; Nicholas Baro; Rachel Daniels; Angana Mukherjee; Lauren M Childs; Caroline Buckee; Manoj T Duraisingh; Sarah K Volkman; Dyann F Wirth; Matthias Marti
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

10.  Elimination of Schistosoma mansoni in infected mice by slow release of artemisone.

Authors:  Daniel Gold; Mohammed Alian; Avraham Domb; Yara Karawani; Maysa Jbarien; Jacques Chollet; Richard K Haynes; Ho Ning Wong; Viola Buchholz; Andreas Greiner; Jacob Golenser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-05-04       Impact factor: 4.077

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.